Background: This study aimed to evaluate clinical features and prognosis and therapy
option of patients with different risk ranks based on antibody against the M-type …

Introduction Clinical course of membranous nephropathy (MN) is difficult to predict.
Measurement of circulating anti-PLA2R autoantibodies (PLA2R-Ab) and detection in …

Background: Membranous Nephropathy (MN) is a rare autoimmune disease related to
PLA2R1 antibodies in 70% of cases. One third of patients enter in spontaneous remission …

Background: The natural course of idiopathic membranous nephropathy (MN) varies, as it is
known through favorable outcomes in most patients. However, one third of patients with …

Background According to renal M type phospholipase A 2 receptor (PLA 2 R)
immunohistochemistry, idiopathic membranous nephropathy (IMN) could be categorized …

Introduction Personalized treatment for patients with membranous nephropathy requires
accurate prediction of the disease course at an early stage. In this study, we evaluated the …

Rationale & Objective Proteinuria and anti–phospholipase A 2 receptor 1 (anti-PLA 2 R1)
antibody titers are associated with primary membranous nephropathy (MN) outcomes. We …

Background Primary membranous nephropathy (PMN) has a heterogeneous natural course.
Immunosuppressive therapy is recommended for PMN patients at moderate or high risk of …

Objective To investigate the correlation of M-type phospholipase A2 receptor (PLA2R)
expression and serum anti-PLA2R antibody with the clinical parameters and prognosis of …

Purpose The meta-analysis aims to investigate the relationship between anti-phospholipase
A2 receptor autoantibody (anti-PLA2R) and clinical characteristics and adverse outcomes of …